Search results
Results From The WOW.Com Content Network
In 2019, Mankind became the first Indian company and second only in the world to develop and launch Dydrogesterone, a drug used in high-risk pregnancies and infertility by the brand name Dydroboon. [24] In 2022, Mankind acquired Panacea Biotec Pharma's domestic formulations brands in India and Nepal for ₹ 1,872 crore (US$220 million). [25]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
(Reuters) - Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.
Ramesh C. Juneja (born 28 July 1955) is an Indian billionaire businessman and the Chairman of Mankind Pharma. [1] He is one of the 100 richest Indians as per Forbes ; [ 2 ] his net worth was estimated to be $2.3 billion in 2019.
CVS Health's Caremark, Cigna's Express Scripts and UnitedHealth Group's Optum control the majority of the U.S. pharmacy benefit market, with their parent companies also operating health insurance ...
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares are trading higher on Monday after the company entered into a merger agreement to be acquired by Immedica Pharma AB, implying an enterprise value ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us